Objective: To examine the clinical burden and disease spectrum, as well as time trends for
human T-cell leukemia virus type 1 (HTLV-1) and HTLV type 2 (HTLV-2) hospital …

Human T-lymphotropic virus type 1 (HTLV-1) infection is a neglected disease despite
roughly 15 million people are chronically infected worldwide. Lifelong less than 10% of …

The presence of antibodies to human T-lymphotropic virus (HTLV) types 1 and 2 was
examined in 5742 sera belonging to consecutive adult outpatients attended during June …

After an HTLV-I endemic area was discovered in Jujuy, a northwestern province in
Argentina, to detect other possible foci of HTLV-I/II we started in 1997 a multicentric study to …

Objectives Although only 10% of persons infected with human T-lymphotropic virus type 1
(HTLV-1) may develop virus-associated illnesses over their lifetime, missing the earlier …

Background The human T-lymphotropic virus type I (HTLV-I) has been implicated in the
genesis of tropical spastic paraparesis (TSP), adult T-cell lymphoma (ATL), and some cases …

2. Rosenthal E, Tempesta S, Giudice P, et al. Declining incidence of visceral leishmaniasis
in HIV-infected individuals in the era of highly active antiretroviral therapy. AIDS 2001; 15 …

Background HTLV-1 infection is a neglected disease, despite producing neurological and
lymphoproliferative severe illnesses and affect over 10 million people worldwide. Roughly …

Aims To assess the prevalence of HTLV-1 and HTLV-2 infections in a cohort of immigrants
living in southern Italy. Findings We screened for antibody to HTLV-1/2 infection 1,498 …

Abstract HTLV-1/2 antenatal screening is not mandatory in European countries. The rapid
increase in immigrants coming from areas endemic for HTLV-1 infection has compelled a …